Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia

Edward D. Huey*, Nicole Armstrong, Parastoo Momeni, Jordan Grafman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Background: Frontotemporal dementia spectrum disorders are a set of neurodegenerative disorders affecting the frontal and anterior temporal lobes. They are often fatal, and currently no medications have been shown to slow their progression. Recent developments in understanding these disorders may aid in developing treatments. Objective: To discuss the development of drug therapies for frontotemporal dementia spectrum disorders, both those under current investigation and those that could be targets for future investigation. Methods: This review is divided into four sections: First, a brief review of frontotemporal dementia spectrum disorders; second, a discussion of the challenges in the development of drug therapies third, a review of the current clinical trials; and finally a discussion of some recent discoveries, which have sparked new areas of investigation. Conclusions: Hopefully, advances in understanding of frontotemporal dementia spectrum disorders and clinical trial design will aid the development of new treatments.

Original languageEnglish (US)
Pages (from-to)1367-1376
Number of pages10
JournalExpert Opinion on Therapeutic Targets
Issue number11
StatePublished - Nov 2008


  • Frontotemporal dementia
  • Medication treatment
  • Neurodegenerative disorders
  • Neuroprotection

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry


Dive into the research topics of 'Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia'. Together they form a unique fingerprint.

Cite this